工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profiles.
Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profiles.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
免疫治疗的最新进展,包括免疫检查点阻断(ICB)和过继细胞治疗,遇到了免疫相关不良事件和耐药性等挑战,尤其是在实体瘤中。为了推动该领域的发展,深入理解治疗反应和耐药性背后的分子机制至关重要。然而,缺乏经过功能表征的免疫相关基因集限制了数据驱动的免疫学研究。为填补这一空白,我们对83个人类bulk RNA-seq数据集采用了非负矩阵分解,并构建了28个免疫特异性基因集。经过免疫学家主导的严格人工注释以及在免疫学背景和功能性组学数据中的正交验证,我们证明这些基因集可应用于细化泛癌免疫亚型、改善ICB反应预测以及对空间转录组数据进行功能注释。这些功能性基因集揭示了多样的免疫状态,将推动我们对免疫学和癌症研究的理解。
Recent developments in immunotherapy, including immune checkpoint blockade (ICB) and adoptive cell therapy, have encountered challenges such as immune-related adverse events and resistance, especially in solid tumors. To advance the field, a deeper understanding of the molecular mechanisms behind treatment responses and resistance is essential.
However, the lack of functionally characterized immune-related gene sets has limited data-driven immunological research. To address this gap, we adopted non-negative matrix factorization on 83 human bulk RNA-seq datasets and constructed 28 immune-specific gene sets.
After rigorous immunologist-led manual annotations and orthogonal validations across immunological contexts and functional omics data, we demonstrated that these gene sets can be applied to refine pan-cancer immune subtypes, improve ICB response prediction and functionally annotate spatial transcriptomic data. These functional gene sets, informing diverse immune states, will advance our understanding of immunology and cancer research.
MEMBER ACCOUNT
登录成功会直接打开下一页。